The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Access · Insurance & coverage · continued

Coverage for the indication versus for the drug — a second dataset posts 31–51

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1 · go to the accepted answer.

BJ
b.jankowiakTL3Regular21 Mar 2025#31

Post #29 put the caveat in the right place and I want to underline it.

I keep a log for Coverage specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and settled it.

4 likes 16mo
JF
j.falkTL221 Mar 2025#32

Building on post #29 rather than restating it.

Coverage is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says which one is being asked for.

0 likes 16mo
YM
y.mensahTL3Wiki editor21 Mar 2025#33
o.lindgren, post #29: Adding what did not work for me on Coverage, since the failures never get written up and they are half the useful information. Go to post

Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer.

If the premise is wrong, everything after it is decoration.

0 likes in reply to #29 16mo
HE
h.espinozaTL222 Mar 2025#34
m.strand_rph, post #23: Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves frustration. That holds under the stated conditions and I have stated them. Go to post

Before the thread moves on from Coverage — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four and from an n of four hundred.

19 likes in reply to #23 16mo
ST
slow_titratorTL2Regular22 Mar 2025#35

Where I part company with post #33, and it is a narrow parting.

Adding the boring version of Coverage, because the interesting version keeps getting posted and the boring one is usually right.

Check the ordinary explanations, in order, and stop when one of them accounts for what you are seeing. Most of the time the second one does.

2 likes 16mo
TK
t.karlsenTL223 Mar 2025#36

Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves frustration.

I would not lead a decision with this, but I would not ignore it either.

0 likes 16mo
WN
w.novakTL3Regular23 Mar 2025 · edited#37
taper_shift, post #1: On the subject in the title: Coverage for the indication versus for the drug — a second dataset Working notes rather than a conclusion. Posting a small dataset on Coverage. It is mine, it is uncontrolled, and the method is stated so it can be discounted appropriately. What I would like is not agreement but a second dataset collected by… Go to post

Where I have landed on Coverage, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has borrowed it from somewhere that did not measure it.

27 likes in reply to #1 16mo
FW
f.weissTL224 Mar 2025#38

Adding the measurement that post #37 says would settle it.

Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.

13 likes 16mo
ED
e.dalgleishTL3Regular24 Mar 2025#39
s.achebe, post #6: For anyone finding this later: the short answer on Coverage is that it depends on one thing, and the rest of the thread is people identifying which thing. Go to post

Small correction to my own earlier position on Coverage. I had the units the wrong way round, which changes the conclusion by an order of magnitude and therefore changes it entirely.

0 likes in reply to #6 16mo
RI
r.ilungaTL225 Mar 2025#40

Worth separating Coverage as a question about the compound from Coverage as a question about the documentation. They get answered by different people and only one of them is answerable here.

0 likes 16mo
ZY
z.yildizTL225 Mar 2025#41

Picking up post #38: that is the part I would want checked first.

Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and appeals based on the covered indication work better.

It reads as pedantry until the day it does not.

11 likes 16mo
VF
v.fontaineTL225 Mar 2025#42

Understood. Thank you for being specific about the limits of it.

24 likes 16mo
HK
h.karlsenTL226 Mar 2025#43
v.fontaine, post #42: Understood. Thank you for being specific about the limits of it. Go to post

Coverage is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.

0 likes in reply to #42 16mo
CA
c.adebayoTL226 Mar 2025#44

Trying to state the Coverage position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes that test.

3 likes 16mo
MI
m.ivaturiTL227 Mar 2025#45

Keep every document with dates in one place. An appeal months later is assembled from whatever you kept.

17 likes 16mo
DB
d.barrosTL227 Mar 2025#46
a.kowalski, post #26: Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves surprise at the pharmacy. That has held every time I have looked, which is not the same as always. Go to post

Post #44 describes the usual case. This is about the unusual one.

Coverage looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.

33 likes in reply to #26 16mo
OC
o.cousineauTL3Regular27 Mar 2025 · edited#47
z.yildiz, post #41: Picking up post #38: that is the part I would want checked first. Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and appeals based on the covered indication work better. It reads as pedantry until the day it does not. Go to post

Confirming post #46 from a second method, which matters more than confirming it from a second person.

Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves surprise at the pharmacy.

That is my reading. Someone else read the same page differently and was reasonable.

1 like in reply to #41 16mo
NV
n.vogelTL228 Mar 2025#48

Where coverage was granted, saying what the successful submission contained is one of the more useful posts on the site.

Worth checking against a second source before it gets quoted onward.

7 likes 16mo
CN
c.niemelTL3Regular28 Mar 2025#49

Coverage would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.

4 likes 16mo
SF
s.ferreiraTL229 Mar 2025#50
m.strand_rph, post #23: Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves frustration. That holds under the stated conditions and I have stated them. Go to post

I think the Coverage question is answerable and has not been answered, which is a more optimistic position than most of this thread.

12 likes in reply to #23 16mo
HN
h.nicolaidesTL329 Mar 2025#51
This topic was closed 60 days after the last reply. Closing is automatic for quiet topics so that a settled answer does not collect new questions underneath it. If you have a follow-up, open a new topic and link back to this one — that keeps both readable and gives your question its own title.

Suggested topics

TopicParticipantsRepliesViewsActivity
External review after an internal denial
External review after an internal denial Writing it up because I had to work it out twice and would rather nobody else did. Proposing that external review deserves a maintained page rather than a recurring…
CNLGRM 2 18k 1mo
Appeal templates and why they are deliberately unemotional — one year on
Appeal templates and why they are deliberately unemotional — one year on Writing it up because I had to work it out twice and would rather nobody else did. A narrow question about Appeal templates,…
BGROB 2 4.1k 11mo
Documentation that materially improves an appeal's chances
Documentation that materially improves an appeal's chances — setting out what I have, and where I think it stops being reliable. An honest uncertainty about documentation rather than a disguised assertion. I…
LIVBSCSDSS+93 98 3.6k 8mo
Step therapy requirements and how to satisfy them
Posting this under the heading it deserves: Step therapy requirements and how to satisfy them Everything below is what sits behind that. I would like to know what people here actually do about step therapy…
APKVVBBNRF+21 25 49k 2mo
Prior authorisation: what the criteria usually require
On the subject in the title: Prior authorisation: what the criteria usually require Working notes rather than a conclusion. I would like to know what people here actually do about prior authorisation, as…
TVFWDSCVCO+9 13 3.2k 17mo

Related topics — sharing the tags prior authorisation, appeals, formulary

TopicParticipantsRepliesViewsActivity
What a good consultation looks like from the other side
What a good consultation looks like from the other side — that is the question, and I have not found it answered plainly anywhere I have looked. Something about good consultation does not reconcile and I…
KFDFIBKPS+57 62 4.9k 22h
Follow-up: External review after an internal denial
Posting this under the heading it deserves: External review after an internal denial Everything below is what sits behind that. Proposing that External review deserves a maintained page rather than a…
RVIWBENK+6 10 12k 15h
Reading a denial letter as a specification for your appeal
Reading a denial letter as a specification for your appeal Writing it up because I had to work it out twice and would rather nobody else did. Reading back through what has been written here about reading a…
SHMARBO 3 30k 12mo
Asking about a compound your prescriber has not heard of — one year on
On the subject in the title: Asking about a compound your prescriber has not heard of — one year on Working notes rather than a conclusion. A question about how to describe something to a clinician rather…
ESMHKDOBSG+11 15 3.7k 19mo
List price versus negotiated price versus what you pay
On the subject in the title: List price versus negotiated price versus what you pay Working notes rather than a conclusion. List price versus negotiated price — I have the observation and I do not trust my…
JPJAVFVBCA+99 115 11k 3mo